CBX7 and prostate carcinoma: Small molecules such as suramin and Ms37452 can inhibit the binding of lysine methylated polypeptides to the CBX7 chromodomain, which can be used as a feasible cancer suppressor in some cancers with high CBX7 expression, such as prostate cancer (Ren et al., 2015).